For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Your partner in science for end-to-end CRDMO solutions

Company Overview

Jubilant Biosys Ltd is a part of the Jubilant Pharmova family of companies with R&D centers in India and business offices in Asia and North America. With our global reach, Jubilant Biosys provides comprehensive drug discovery services and contract research services–from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared)–in partnership with leading worldwide healthcare companies..

company overview - jubilant biosys

A Leading PreClinical Contract Research Organisation

With a clear scientific focus in oncology, metabolic disorders, central nervous system (CNS) diseases, pain and inflammation, Jubilant Biosys has rapidly emerged as a leading collaborator for pharmaceutical and biotechnology companies worldwide. In each of these therapeutic areas, Jubilant Biosys has developed a deep level of expertise in discovery informatics, computational chemistry, medicinal chemistry, structural biology, biology, in-vivo, in-vitro models and translational sciences. Combined with strong clinical development and manufacturing capabilities from other Jubilant subsidiaries, Jubilant Biosys has risen as a fully integrated contract research organization in India and headquartered at Bengaluru with end-to-end solutions.

Our ability to be the preferred collaborator in the drug discovery domain is sustained by our commitment to comply with and continually improve our quality systems and to provide the following services:

Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.

Why Jubilant Biosys?

  • A highly experienced scientific team that has delivered >85 integrated Drug Discovery programs.
  • New technologies applied to accelerate drug discovery and improve decision-making quality
  • A boutique CRO with a talented team of >800 scientists giving your program priority
  • Investing in the future of drug discovery and development through expansion
  • Leadership with a global pedigree in the US, EU and Japan

Innovative and rigorous science, excellence in execution, and absolute integrity combined with flexible business models have enabled Jubilant Biosys to deliver valuable outcomes in a relatively short time. The hallmark of Jubilant Biosys’s collaborative model is the creation of value to their partners.

The Jubilant Advantage

  • Target validation to proof of concept
  • Largest pool of drug discovery talent in India
  • Diverse discovery technologies
  • Creative partnering/collaboration models
  • Experienced portfolio management capabilities

About Jubilant Pharmova
(Our Parent Company)

Pharmova is born out of a combination of ‘Pharma’ and ‘Nova’ (New) and Jubilant Pharmova Limited will continue to focus on offering products and services with, excellence in research and manufacturing, catering to the unmet health needs at an affordable price.

Jubilant Pharmova Limited is an integrated global pharmaceutical company involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.

In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules.